CPC Acquires Drug Free Sport International from Valesco Industries

PCF Insurance Services Acquires Direct Dealer Services

December 7, 2022

Insurance

PCF Insurance Services, a top-20 U.S. insurance brokerage based in Lehi, Utah, has acquired Direct Dealer Services (DDS), an automotive finance & insurance (F&I) firm headquartered in Hoffman Estates, Illinois. The acquisition expands PCF's F&I capabilities and product offerings for dealer, agent and lender partners; terms were not disclosed.

SFEP-backed SV Labs Acquires Diversified Manufacturing Corporation

January 13, 2022

Manufacturing

San Francisco Equity Partners-backed portfolio company SV Labs has acquired Diversified Manufacturing Corporation (DMC), a Prescott, Wisconsin-based contract manufacturer of beauty and personal care products. The acquisition expands SV Labs' manufacturing capacity and capabilities (including cGMP and OTC production and high-speed liquid filling) and adds a major Midwest facility to serve CPG, DTC and retail customers.

CPC, LLC Acquires Component Sourcing International (CSI)

September 13, 2022

Industrial Services

CPC, LLC has completed the acquisition of Component Sourcing International (CSI), a Charlotte, North Carolina-based global supply chain and sourcing specialist, from CSI's management team and Argosy Capital. CPC — a permanent-capital investment vehicle owned by family offices — will keep CSI’s existing leadership in place and pursue long-term growth and capability investments in the business.

Cobepa Reinforces Stake and FFP Takes Minority Interest in International SOS

February 1, 2021

Healthcare Services

Belgian investment firm Cobepa has reinforced its shareholding in International SOS while French investor FFP has acquired a minority interest in the company. The investment underlines long-term support for International SOS, a global provider of medical prevention, security and emergency assistance services operating across dozens of countries.

Alliance Pharma (Ampersand-backed) Acquires LGC's Drug Development Solutions; KKR Joins as Equal Shareholder

May 17, 2022

Healthcare Services

Alliance Pharma, an Ampersand-backed US bioanalytical CRO, acquired Drug Development Solutions (DDS), LGC’s UK-based bioanalytical and materials science testing business. Ampersand Capital Partners and KKR will be equal shareholders in the combined business to expand geographic reach, broaden laboratory capabilities, and extend the service portfolio internationally.

Fortis Life Sciences Acquires International Point of Care

July 12, 2023

Medical Devices

Fortis Life Sciences, LLC has acquired Toronto-based International Point of Care, Inc. (IPOC). The acquisition adds IPOC’s 36,000 sq. ft. GMP and ISO 13485:2016 manufacturing facility and capabilities (lyophilized reagents, membranes, recombinant proteins, and controls) to Fortis’ diagnostics manufacturing platform, enabling end-to-end customizable solutions for immunodiagnostic and molecular diagnostic customers.